Health2h ago
Stem cell therapy for autism only in approved clinical trials: Centre
AI EXECUTIVE SUMMARY
Indian authorities have issued an advisory stating that unapproved stem cell therapies, such as those marketed for autism, must not be administered as standard or commercial medical treatments. The guidance emphasizes that such interventions should only take place within the framework of authorized clinical trials to ensure patient safety and regulatory compliance.
WHY IT MATTERS
This advisory directly impacts families seeking alternative autism treatments by restricting access to commercial stem cell therapies outside of strict clinical trial settings.
Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory said
This story was originally reported by The Hindu — Health. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.
ALSO REPORTED BY OTHER SOURCES (1)
Only Prime Minister’s Office can grant sanction to prosecute IAS officers, Centre tells Madras High Court
Community Sentiment & Coverage Reliability
Crowd-sourced evaluation based on verified reader feedback
Rate Coverage Tone:
No reader evaluations recorded yet — be the first to rate the coverage tone above!
Quick Story Reactions:
Community Discussion (0)
Join the Community Discussion
Sign in or create a free reader account to post comments, upvote analysis, and share your perspective.